Company intelligence / Profile preview

Polymedco

Cortlandt Manor, New York, United Statesidga.org ↗

Ownership: Private
Employees: ~112
Development stage: Commercial

Overview

Polymedco markets and distributes FDA-cleared diagnostic products for early detection of life-threatening diseases. Its OC-Auto FIT test plays a pivotal role in noninvasive colorectal cancer screening. The company also offers cardiac biomarker analyzers for acute myocardial infarction diagnosis. Products are supported by robust clinical evidence and are widely used in healthcare systems across the US.

Therapeutic areas: OncologyCardiovascular
Modalities: DeviceNon-pharmacological therapy
Industry: Protein Biomarker Diagnostics

Drug pipeline

2 assets

OC-Auto FIT

Commercial

Indications: Colorectal cancer

1 more asset in the full pipeline.

Request access →

Partnerships

RoundTable Healthcare Partners

Beyond the preview

Go deeper on Polymedco.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Polymedco.

Explore the full profile